Measuring Quality of Life in Deprescribing Trials: A Scoping Review

ConclusionsSeveral existing QoL scales have been applied to the context of deprescribing/polypharmacy clinical trials, and new scales specific to the problem have been proposed. If deprescribing does impact QoL, our findings suggest it is uncertain whether existing QoL scales can practically and reliably capture such a change or whether any scale is best. However, this review compares various aspects of the scales that researchers and clinicians can consider in decisions about measuring QoL in deprescribing trials, and in planning future research.Protocol RegistrationOpen Science Framework: osf.io/aez6w.
Source: Drugs and Aging - Category: Geriatrics Source Type: research